3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
35
Carcinoma, Non-Small-Cell Lung
27
Breast Neoplasms
15
Lung Neoplasms
13
Neoplasm Metastasis
12
Triple Negative Breast Neoplasms
11
Neoplasms
10
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Head and Neck Neoplasms
4
Carcinoma, Pancreatic Ductal
4
Stomach Neoplasms
3
Neoplasms by Site
3
Gastrointestinal Neoplasms
3
Carcinoma
3
Adenocarcinoma
3
Vaccinia
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms by Histologic Type
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Interventions
Paclitaxel
10
Carboplatin
6
Bevacizumab
5
liposomal doxorubicin
4
Topotecan
3
Cyclophosphamide
3
pembrolizumab
2
oregovomab
2
olaparib
2
niraparib
2
fludarabine
2
Nivolumab
2
Drug Therapy
2
trastuzumab deruxtecan
1
rucaparib
1
ribociclib
1
palbociclib
1
mirvetuximab soravtansine
1
isoquercitrin
1
irinotecan sucrosofate
1
fludarabine phosphate
1
denileukin diftitox
1
anlotinib
1
Tinzaparin
1
Saline Solution
1
Propranolol
1
Preoperative Exercise
1
Platinum
1
Palliative Care
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
130-nm albumin-bound paclitaxel
×
90 days
×
Clear all
No trials found.